GE Healthcare Life Sciences
Biacore Life Sciences
You are here: Biacore Life Sciences > LMW Drug discovery > Compound characterization > References
IntroductionApplication PresentationsReferences
printer friendly
back

References

Label-free kinetic binding data as a decisive element in drug discovery
K. Andersson, R. Karlsson, S. Löfås, G. Franklin and M. Hämäläinen
Expert Opin Drug Discov 1: 439-46 (2006)

This review summarizes findings in the literature related to compound selection in the drug discovery process. By performing parallel optimizations of association and dissociation rates, compounds with desirable kinetic profiles for target binding may be generated. In addition, compound selection may also consider the kinetic properties of ADME marker binding profiles, further refining the quality of compounds early in the drug discovery process.

Link to abstract
Studies of small molecule interactions with protein phosphatases using biosensor technology
P. Stenlund, A. Frostell-Karlsson and O. P. Karlsson
Anal Biochem 353: 217-25 (2006)
On the identification of phosphatases as useful targets for therapeutic intervention. A method using Biacore T100 is presented for analyzing the specificity of small molecule inhibitors for phosphatases. Data is also presented on compound binding that is independent of enzyme activity and in which affinities are resolved into kinetic rate constants.
Link to abstract
Kinetic studies of small molecule interactions with protein kinases using biosensor technology
H. Nordin, M. Jungnelius, R. Karlsson and O. P. Karlsson
Anal Biochemistry 340: 359-68 (2005)

A “must read” for anyone doing small molecule assays. This paper illustrates applications of Biacore besides direct binding kinetics and affinity e.g. to measure the effect of binders on kinase activity and competition studies.

Link to abstract
Probing the mechanism of drug/lipid membrane interactions using Biacore
Y. N. Abdiche and D. G. Myszka
Anal Biochem 328: 233-43 (2004)

A comparison between Biacore results and those from a PAMPA (parallel artificial membrane permeability assay), which was in common usage, prior to Biacore, for determining lipid retention of small molecules.  The authors were able to use the Biacore data to discriminate structurally related compounds.

Link to abstract
Biosensor analysis of the interaction between drug compounds and liposomes of different properties; a two-dimensional characterization tool for estimation of membrane absorption
A. Frostell-Karlsson, H. Widegren, C. E. Green, M. D. Hamalainen, L. Westerlund, R. Karlsson, K. Fenner and H. van de Waterbeemd
J Pharm Sci 94: 25-37 (2004)

An approach for studying drug-lipid interactions in early in vitro ADME applications, using two types of immobilized liposomes for simultaneous resolution of lipid absorption characteristics. The paper provides a “how-to” guide and highlights the advantages for drug discovery applications compared to existing methods.

Link to abstract
Kinetic and thermodynamic characterization of HIV-1 protease inhibitors
F. S. Shuman, M. D. Hämäläinen and U. H. Danielson
J Mol Recognit 17: 106-19 (2004)

Experimental procedures are described in detail as well as the calculations required to obtain thermodynamic constants (ΔG, ΔS, ΔH).

Link to abstract
Kinetic and mechanistic analysis of the association and dissociation of inhibitors interacting with secreted aspartic acid proteases 1 and 2 from Candida albicans
D. Backman and U. H. Danielson
Biochim Biophys Acta 1646: 184-95 (2003)

Data are presented as on-rate/off-rate plots under different pH conditions. Includes a discussion on why biotinylation is better than amine coupling for ligands with low pI values. Also discusses the importance of on and off rates compared with affinity measurements alone.

Link to abstract
Analysis of membrane-binding properties of dermaseptin analogues: relationships between binding and cytotoxicity
L. Gaidukov, A. Fish and A. Mor
Biochemistry 42: 12866-74 (2003)

On peptide binding and absorption into lipid membranes as a proposed antibiotic delivery strategy. Recommended for those skeptical about the merits of Biacore compared with solution-based methods!

Link to abstract
Surface plasmon resonance characterization of drug/liposome interactions
C. L. Baird, E. S. Courtenay and D. G. Myszka
Anal Biochem 310: 93-9 (2002)

How to mesaure binding of drugs to liposomes. Reproducibility of liposome capture, relative drug binding responses, kinetics of drug binding, liposome capture with lipids of various composition, effect of amount of captured liposome on drug binding, comparison of drug/lipid interactions under different experimental conditions

Link to abstract
Relationships between structure and interaction kinetics for HIV-1 protease inhibitors
P. O. Markgren, W. Schaal, M. Hamalainen, A. Karlen, A. Hallberg, B. Samuelsson and U. H. Danielson
J Med Chem 45: 5430-9 (2002)
Link to abstract